REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$776.03
arrow_downward
-2.23%(-17.71) 1D
Sep 15, 10:43:53 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$788.53
High
$788.58
Low
$774.21
Mkt. cap
79.90B
Avg. vol.
675.80K
Volume
76.50K
Dividend
0.48%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.19
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
Open
$788.53
High
$788.58
Low
$774.21
Mkt. cap
79.90B
Avg. vol.
675.80K
Volume
76.50K
Dividend
0.48%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.19
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
The National Law Review
·
2 hours ago
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc
Yahoo Finance
·
8 hours ago
Regeneron Pharmaceuticals (REGN) Could Be 5% Undervalued Following Trial Lawsuit News
News Corp
·
18 hours ago
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com